Diffuse large B-cell lymphoma: open trials in Denmark

8 open trials have a site in Denmark. Registry data; only the trial team decides who can take part.

NCT05139017
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Region Midtjylland, Aarhus N
Registry updated 2026-11-03
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rigshospitalet, Copenhagen Oe
Registry updated 2026-10-30
2025-524230-25-00
HOVON 168:Study on epcoritamab in frail patients with diffuse large B-Cell lymphoma (DLBCL) who have not been treated before
Trial Treatment · Phase 2 · Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting
Article 11 CTR DK, DO NOT EDIT
Registry updated 2026-10-27
2025-521205-41-00
A Randomized, placebo-controlled, double-blinded Phase 2 Trial of Dapagliflozin for Preventing Treatment-associated Cardiotoxicity in Lymphoma
Trial Treatment · Phase 2 · Aalborg University Hospital
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Region Midtjylland, Herning · Region Sjaelland, Koege · Odense University Hospital, Odense C · Lillebaelt Hospital, Vejle
Registry updated 2026-10-23
NCT06717347
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Aalborg University Hospital, Aalborg · Region Midtjylland, Aarhus N · Region Midtjylland, Herning · Odense University Hospital, Odense C
Registry updated 2026-10-21
NCT07195916
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Trial Treatment · Phase 1 · Incyte Corporation
Department of Hematology'S Research Unit and Laboratories At Aarhus University Hospital, Aarhus · Rigshospitalet Uni of Hospital of Copenhagen, Copenhagen
Registry updated 2026-10-09
NCT07817641
Proton Therapy for Mediastinal Lymphoma (PROMLY)
Trial Treatment · Copenhagen University Hospital, Rigshospitalet
Dept. of oncology, Copenhagen
Registry updated 2026-09-14
NCT04332822
A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma
Trial Treatment · Phase 3 · Nordic Lymphoma Group
Aalborg University Hospital, Aalborg · Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen Oe · Sydvestjysk Sygehus, Esbjerg · Region Midtjylland, Herning · Region Sjaelland, Koege · Odense University Hospital, Odense C · Vejle Hospital, Vejle
Registry updated 2024-09-19

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error